---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-086639"
form_type: "8-K"
ticker: "APM"
cik: "0001734005"
company_name: "Aptorum Group Ltd"
filed_at: "2026-08-07T20:00:46+00:00"
generated_at: "2026-08-07T20:02:04.324339+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Niki BioSolutions regains Nasdaq minimum bid price compliance

## Summary
- Received Nasdaq deficiency letter on March 5, 2026 for bid price below $1.00 for 30 consecutive business days.
- On August 4, 2026, Nasdaq confirmed compliance as closing bid price was $1.00+ for 10 consecutive days (July 21-Aug 3, 2026).
- Listing matter now closed; company avoids delisting from Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001213900-26-086639
- form_type: 8-K
- ticker: APM
- cik: 0001734005
- company_name: Aptorum Group Ltd
- filed_at: 2026-08-07T20:00:46+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1734005/000121390026086639/0001213900-26-086639-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1734005/000121390026086639/ea0300774-8k_nikibio.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-086639
- JSON: https://secwatch.observer/filing/0001213900-26-086639.json
- Plain text: https://secwatch.observer/filing/0001213900-26-086639.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.